摘要
目的:探讨外周血髓样相关蛋白8/14(myeloid—related protein 8/14,MRP8/14)对痛风急性发作的诊断价值及对后续治疗的指导意义。方法:选取门诊就诊的痛风急性发作患者40例、痛风间歇期患者24例以及健康体检志愿者12例;采用酶联免疫吸附法(enzyme-linked immunosorbent assay,ELISA)定量检测血清MRP8/14水平,其中32例急性期患者在症状缓解前后均行测定。结果:痛风急性发作患者血清MRP8/14水平高于间歇期患者及健康体检者(P〈0.01);急性发作患者症状缓解后MRP8/14水平低于发作期(P〈0.01);间歇期患者MRP8/14水平与健康体检者比较差异无统计学意义(P〉0.05);MRP8/14水平与血沉(erythrocyte sedimentation rate,ESR)及高敏C-反应蛋白(high—sensitivity C-reactive protein,hs—CRP)无明显相关性。根据受试者工作特征(receiver operating characteristic,ROC)曲线得出,MRP8/14诊断痛风急性发作的最佳分界值(cut-off值)为504.00mg/L,ROC曲线下面积为0.852(95%CI:0.770-0.934),灵敏度和特异度分别为77.5%、77.8%。结论:MRPS/14在痛风急性发作期升高,且独立于ESR及hs—CRP水平,而MRP8/14在间歇期患者中的表达水平接近于健康人,可作为急性发作的生化标志物。
Objective:To investigate the value of myeloid-related protein 8/14 (MRP8/14) in the diagnosis and following treatment of acute attack of gout. Methods: A total of 40 patients with gout in acute attack, 24 patients with gout in intermission and 12 healthy people were enrolled. MRP8/14 expression was tested by enzyme-linked immunosorbent assay(ELISA). Results: MRP8/14 level in patients with gout in acute attack was higher than those in intermission and healthy people (P〈0.01). MRP8/14 showed significant reduction after treatment, compared with acute attack period(P〈0.01). MRP8/14 level had no significant difference between patients with gout in intermission and healthy people (P〉0.05). MRP8/14 was not related to the level of erythrocyte sedimentation rate(ESR) or high-sensitivity C-reactive protein(hs-CRP). Receiver operating characteristic (ROC) curve analysis was used to determine the cut-off value of this assay for identifying individuals with acute attack. The sensitivity and specificity at the optimal cut-off value of 504.00 mg/L were 77.5% and 77.8%. The area under ROC curve was 0. 852(95 %CI:0. 770-0. 934). Conclusions: MRP8/14 expression increases in acute attack of gout, and it is not relevant to ESR or hs-CRP. MRP 8/14 expression decreases after symptom remission. MRP8/14 can be regarded as a biochemical marker for acute attack of gout.
出处
《中国临床医学》
2014年第2期115-117,共3页
Chinese Journal of Clinical Medicine
基金
上海市科委基础研究重大项目(编号:11DJ1400100)